苑东生物发布前三季度业绩，归母净利润2.2亿元，同比增长1.45%

Core Viewpoint - Yuan Dong Biotech (688513.SH) reported a slight decline in revenue for the first three quarters of 2025, while net profit showed a modest increase, indicating a mixed performance in the company's financial health [1] Financial Performance - The company achieved a revenue of 1.019 billion yuan for the first three quarters, representing a year-on-year decrease of 2% [1] - The net profit attributable to shareholders was 220 million yuan, reflecting a year-on-year increase of 1.45% [1] - The non-recurring net profit was 173 million yuan, which is a year-on-year growth of 3.10% [1] - Basic earnings per share stood at 1.25 yuan [1]